SCHEMBL23809170

SCHEMBL23809170

Cc1cc(C(C)C)c2c(c1)cc(C(=O)O)n2C

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 5/20 0.47
ALDH1A1 P00352 5/20 0.47
HPGD P15428 4/20 0.47
KDM4E B2RXH2 4/20 0.47
MCL1 Q07820 2/20 0.42
GPR35 Q9HC97 1/20 0.42
GFER P55789 2/20 0.41
GAA P10253 2/20 0.39
SMN1; SMN2 Q16637 1/20 0.38
FABP3 P05413 1/20 0.36
FABP4 P15090 1/20 0.36
MAPK1 P28482 1/20 0.35
PHGDH O43175 1/20 0.34
TPMT P51580 1/20 0.33
DHODH Q02127 1/20 0.33
SRD5A2 P31213 1/20 0.33
MAPT P10636 1/20 0.33
THRB P10828 1/20 0.33
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23809201 0.86 ALDH1A1 (0.33) HSD17B10ALDH1A1HPGDKDM4ETHRB
SCHEMBL23809313 0.86 HSD17B10 (0.46) HSD17B10ALDH1A1HPGDKDM4EMCL1
SCHEMBL23809290 0.82 KDM4E (0.54) HSD17B10ALDH1A1HPGDKDM4EMCL1
SCHEMBL23809370 0.81 DHODH (0.39) HSD17B10ALDH1A1HPGDKDM4EMCL1
SCHEMBL26581225 0.80 HSD17B10 (0.51) HSD17B10ALDH1A1HPGDKDM4EMCL1
SCHEMBL23809489 0.79 HSD17B10 (0.46) HSD17B10ALDH1A1HPGDKDM4EMCL1
SCHEMBL23809518 0.78 HSD17B10 (0.39) HSD17B10ALDH1A1HPGDKDM4EMCL1
SCHEMBL23809284 0.78 ALDH1A1 (0.38) HSD17B10ALDH1A1HPGDKDM4EMCL1
SCHEMBL23809536 0.77 ALDH1A1 (0.33) HSD17B10ALDH1A1HPGDKDM4EMCL1
SCHEMBL23809171 0.76 HSD17B10 (0.46) HSD17B10ALDH1A1HPGDKDM4EMCL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210283138-A1 SUBSTITUTED INDOLE MCL-1 INHIBITORS VANDERBILT UNIVERSITY 2021-09-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210283138-A1 SUBSTITUTED INDOLE MCL-1 INHIBITORS MCL1, BCL2L1, BCL9 HSD17B10 3627/4885ALDH1A1 2556/4885HPGD 3190/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.